BioMarin Pharmaceutical ROE 2006-2020 | BMRN

Current and historical return on equity (ROE) values for BioMarin Pharmaceutical (BMRN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. BioMarin Pharmaceutical ROE for the three months ending March 31, 2020 was 4.40%.
BioMarin Pharmaceutical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $0.11B $3.24B 3.68%
2019-12-31 $-0.02B $3.12B -0.76%
2019-09-30 $-0.04B $3.07B -1.41%
2019-06-30 $-0.11B $2.96B -3.73%
2019-03-31 $-0.09B $2.94B -3.08%
2018-12-31 $-0.08B $2.97B -2.70%
2018-09-30 $-0.13B $2.92B -4.38%
2018-06-30 $-0.13B $2.89B -4.42%
2018-03-31 $-0.15B $2.81B -5.17%
2017-12-31 $-0.12B $2.81B -4.18%
2017-09-30 $-0.16B $2.81B -5.63%
2017-06-30 $-0.18B $2.80B -6.60%
2017-03-31 $-0.56B $2.77B -22.30%
2016-12-31 $-0.63B $2.77B -26.20%
2016-09-30 $-0.47B $2.65B -20.31%
2016-06-30 $-0.52B $1.92B -23.55%
2016-03-31 $-0.19B $2.29B -8.01%
2015-12-31 $-0.17B $2.40B -7.26%
2015-09-30 $-0.31B $2.29B -14.46%
2015-06-30 $-0.21B $2.36B -10.90%
2015-03-31 $-0.17B $2.43B -9.53%
2014-12-31 $-0.14B $1.53B -9.06%
2014-09-30 $-0.13B $1.51B -8.80%
2014-06-30 $-0.19B $1.46B -13.50%
2014-03-31 $-0.18B $1.46B -13.12%
2013-12-31 $-0.18B $1.34B -13.81%
2013-09-30 $-0.17B $1.28B -14.00%
2013-06-30 $-0.12B $1.26B -10.58%
2013-03-31 $-0.13B $1.25B -12.15%
2012-12-31 $-0.11B $1.02B -11.99%
2012-09-30 $-0.09B $1.02B -9.89%
2012-06-30 $-0.10B $1.00B -12.17%
2012-03-31 $-0.07B $0.77B -9.70%
2011-12-31 $-0.05B $0.77B -7.20%
2011-09-30 $-0.04B $0.78B -5.30%
2011-06-30 $0.20B $0.73B 28.45%
2011-03-31 $0.20B $0.72B 33.68%
2010-12-31 $0.21B $0.72B 40.97%
2010-09-30 $0.22B $0.59B 55.20%
2010-06-30 $0.01B $0.36B 3.90%
2010-03-31 $0.01B $0.35B 4.47%
2009-12-31 $0.00B $0.32B 0.00%
2009-09-30 $0.02B $0.30B 7.03%
2009-06-30 $0.01B $0.28B 5.22%
2009-03-31 $0.02B $0.27B 6.70%
2008-12-31 $0.03B $0.28B 13.47%
2008-09-30 $0.01B $0.24B 4.65%
2008-06-30 $0.00B $0.23B 2.01%
2008-03-31 $-0.00B $0.21B -2.16%
2007-12-31 $-0.02B $0.19B -8.62%
2007-09-30 $-0.01B $0.18B -7.67%
2007-06-30 $-0.01B $0.17B -9.77%
2007-03-31 $-0.01B $0.17B -9.69%
2006-12-31 $-0.01B $0.12B -14.33%
2006-09-30 $-0.02B $0.12B -48.57%
2006-06-30 $-0.03B $0.05B 212.77%
2006-03-31 $-0.05B $0.05B 87.38%
2005-12-31 $-0.06B $-0.08B 66.67%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $21.698B $1.704B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.474B 15.37
Bristol Myers Squibb (BMY) United States $138.771B 10.69
CSL (CSLLY) Australia $91.109B 0.00
Gilead Sciences (GILD) United States $86.313B 12.42
Vertex Pharmaceuticals (VRTX) United States $71.196B 39.73
Regeneron Pharmaceuticals (REGN) United States $68.344B 25.27
Illumina (ILMN) United States $58.702B 67.80
Biogen (BIIB) United States $43.957B 7.52
Seattle Genetics (SGEN) United States $28.153B 0.00
Moderna (MRNA) United States $27.381B 0.00
Genmab (GMAB) Denmark $23.747B 19.54
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.603B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.772B 9.49
Genmab (GNMSF) Denmark $22.430B 66.59
Incyte (INCY) United States $21.268B 0.00
BeiGene (BGNE) Cayman Islands $20.021B 0.00
BioNTech SE (BNTX) Germany $17.440B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.625B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.581B 70.47
Horizon Therapeutics Public (HZNP) Ireland $14.911B 34.89
Exact Sciences (EXAS) United States $13.575B 0.00
Galapagos (GLPG) Belgium $12.242B 36.01
Sarepta Therapeutics (SRPT) United States $12.123B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.864B 0.00
QIAGEN (QGEN) Netherlands $10.675B 27.09
Bio-Techne Corp (TECH) United States $10.188B 70.52
Immunomedics (IMMU) United States $9.981B 0.00
Novavax (NVAX) United States $9.708B 0.00
Repligen (RGEN) United States $8.121B 128.89
Guardant Health (GH) United States $7.826B 0.00
Ascendis Pharma (ASND) Denmark $7.739B 0.00
Exelixis (EXEL) United States $6.995B 25.63
ACADIA Pharmaceuticals (ACAD) United States $6.800B 0.00
Emergent Biosolutions (EBS) United States $6.719B 26.62
CRISPR Therapeutics AG (CRSP) Switzerland $6.522B 202.04
SWEDISH ORP BIO (BIOVF) Sweden $6.510B 16.19
Vir Biotechnology (VIR) United States $5.914B 0.00
Acceleron Pharma (XLRN) United States $5.730B 0.00
Mirati Therapeutics (MRTX) United States $5.654B 0.00
MyoKardia (MYOK) United States $5.315B 0.00
Adaptive Biotechnologies (ADPT) United States $5.141B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.123B 0.00
Reata Pharmaceuticals (RETA) United States $5.049B 0.00
Zai Lab (ZLAB) China $4.723B 0.00
NeoGenomics (NEO) United States $4.418B 1333.67
MorphoSys AG (MOR) Germany $4.298B 56.33
Bluebird Bio (BLUE) United States $4.228B 0.00
China Biologic Products (CBPO) China $4.204B 23.37
Blueprint Medicines (BPMC) United States $4.125B 0.00
Halozyme Therapeutics (HALO) United States $3.975B 0.00
Amicus Therapeutics (FOLD) United States $3.955B 0.00
Global Blood Therapeutics (GBT) United States $3.930B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.814B 0.00
Arena Pharmaceuticals (ARNA) United States $3.726B 0.00
Denali Therapeutics (DNLI) United States $3.344B 0.00
Sorrento Therapeutics (SRNE) United States $3.294B 0.00
Inovio Pharmaceuticals (INO) United States $3.214B 0.00
Insmed (INSM) United States $2.982B 0.00
Alkermes (ALKS) Ireland $2.965B 62.13
Fate Therapeutics (FATE) United States $2.902B 0.00
Principia Biopharma (PRNB) United States $2.882B 0.00
Amarin (AMRN) Ireland $2.718B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.700B 0.00
Twist Bioscience (TWST) United States $2.692B 0.00
Editas Medicine (EDIT) United States $2.035B 0.00
PHARMA MAR SA (PHMMF) Spain $1.936B 0.00
UniQure (QURE) Netherlands $1.860B 0.00
Ligand Pharmaceuticals (LGND) United States $1.853B 62.74
Mesoblast (MESO) Australia $1.810B 0.00
Viela Bio (VIE) United States $1.788B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.682B 40.04
I-Mab (IMAB) China $1.655B 0.00
Sangamo Therapeutics (SGMO) United States $1.652B 0.00
Eidos Therapeutics (EIDX) United States $1.596B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.554B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.478B 0.00
Zymeworks (ZYME) Canada $1.431B 0.00
Adverum Biotechnologies (ADVM) United States $1.428B 0.00
Zealand Pharma (ZEAL) Denmark $1.373B 0.00
Mersana Therapeutics (MRSN) United States $1.370B 0.00
Intra-Cellular Therapies (ITCI) United States $1.368B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.365B 0.00
Revance Therapeutics (RVNC) United States $1.345B 0.00
Epizyme (EPZM) United States $1.302B 0.00
NGM Biopharmaceuticals (NGM) United States $1.291B 0.00
Cytokineticsorporated (CYTK) United States $1.287B 0.00
REGENXBIO (RGNX) United States $1.277B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Beam Therapeutics (BEAM) United States $1.262B 0.00
Coherus BioSciences (CHRS) United States $1.235B 7.25
Alector (ALEC) United States $1.198B 0.00
Akcea Therapeutics (AKCA) United States $1.165B 0.00
Arvinas (ARVN) United States $1.160B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.158B 0.00
Alcobra (ARCT) United States $1.156B 0.00
Compugen (CGEN) Israel $1.126B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.049B 0.00
NantKwest (NK) United States $1.035B 0.00
Intellia Therapeutics (NTLA) United States $1.027B 0.00
VBI Vaccines (VBIV) United States $0.973B 0.00
Retrophin (RTRX) United States $0.973B 0.00
Heska (HSKA) United States $0.972B 0.00
Arcus Biosciences (RCUS) United States $0.966B 0.00
Myriad Genetics (MYGN) United States $0.924B 47.65
Athenex (ATNX) United States $0.898B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.856B 0.00
Intrexon (PGEN) United States $0.820B 0.00
Dynavax Technologies (DVAX) United States $0.813B 0.00
Cara Therapeutics (CARA) United States $0.795B 0.00
Codexis (CDXS) United States $0.758B 0.00
Morphic Holding (MORF) United States $0.750B 0.00
Pharming Group (PHGUF) Netherlands $0.745B 17.00
Autolus Therapeutics (AUTL) United Kingdom $0.726B 0.00
Cellectis S.A (CLLS) France $0.718B 0.00
Castle Biosciences (CSTL) United States $0.717B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.686B 0.00
Vericel (VCEL) United States $0.684B 0.00
MiMedx (MDXG) United States $0.662B 0.00
Frequency Therapeutics (FREQ) United States $0.658B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.627B 5.50
Kadmon Holdings (KDMN) United States $0.611B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Cue Biopharma (CUE) United States $0.570B 0.00
Agenus (AGEN) United States $0.567B 0.00
Syros Pharmaceuticals (SYRS) United States $0.550B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.541B 0.00
Prothena (PRTA) Ireland $0.515B 0.00
Athersys (ATHX) United States $0.511B 0.00
Kala Pharmaceuticals (KALA) United States $0.500B 0.00
MeiraGTx Holdings (MGTX) United States $0.488B 0.00
AnaptysBio (ANAB) United States $0.485B 0.00
IBio (IBIO) United States $0.481B 0.00
Clovis Oncology (CLVS) United States $0.479B 0.00
Innate Pharma S.A (IPHA) France $0.478B 0.00
Anika Therapeutics (ANIK) United States $0.476B 20.84
UROGEN PHARMA (URGN) United States $0.473B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.470B 0.00
Cel-Sci (CVM) United States $0.460B 0.00
BioDelivery Sciences (BDSI) United States $0.455B 32.21
Protagonist Therapeutics (PTGX) United States $0.451B 0.00
AC Immune SA (ACIU) Switzerland $0.446B 0.00
Avid Bioservices (CDMO) United States $0.433B 0.00
Prometic Life Sciences (LMNL) Canada $0.427B 0.00
Scholar Rock Holding (SRRK) United States $0.411B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.410B 0.00
Puma Biotechnology (PBYI) United States $0.409B 0.00
PDL BioPharma (PDLI) United States $0.399B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.395B 0.00
Kamada (KMDA) Israel $0.387B 16.11
Merus (MRUS) Netherlands $0.387B 0.00
MannKind (MNKD) United States $0.380B 0.00
Albireo Pharma (ALBO) United States $0.372B 0.00
Biofrontera AG (BFRA) Germany $0.370B 0.00
ANI Pharmaceuticals (ANIP) United States $0.364B 8.58
Precision BioSciences (DTIL) United States $0.359B 0.00
CytomX Therapeutics (CTMX) United States $0.347B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.344B 0.00
Seres Therapeutics (MCRB) United States $0.338B 0.00
Geron (GERN) United States $0.338B 0.00
WAVE Life Sciences (WVE) Singapore $0.321B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.308B 0.00
ChromaDex (CDXC) United States $0.302B 0.00
Arbutus Biopharma (ABUS) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.293B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.288B 0.00
Affimed (AFMD) Germany $0.288B 0.00
OSMOTICA PHARM (OSMT) United States $0.276B 0.00
Menlo Therapeutics (MNLO) United States $0.267B 0.00
Cellular Biomedicine (CBMG) United States $0.265B 0.00
Celldex Therapeutics (CLDX) United States $0.264B 0.00
NextCure (NXTC) United States $0.264B 0.00
Spero Therapeutics (SPRO) United States $0.261B 0.00
Trevena (TRVN) United States $0.260B 0.00
DBV Technologies S.A (DBVT) France $0.255B 0.00
Pfenex (PFNX) United States $0.254B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
Northwest Biotherapeutics (NWBO) United States $0.246B 0.00
Fortress Biotech (FBIO) United States $0.242B 0.00
Verastem (VSTM) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
Dyadic (DYAI) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.236B 0.00
HOOKIPA Pharma (HOOK) United States $0.233B 0.00
Pluristem Therapeutics (PSTI) Israel $0.232B 0.00
Five Prime Therapeutics (FPRX) United States $0.224B 0.00
Selecta Biosciences (SELB) United States $0.220B 0.00
IVERIC Bio (ISEE) United States $0.220B 0.00
Strongbridge Biopharma (SBBP) United States $0.217B 0.00
Aduro Biotech (ADRO) United States $0.205B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 9.50
Exicure (XCUR) United States $0.201B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.193B 0.00
Theratechnologies (THTX) Canada $0.185B 0.00
Aptinyx (APTX) United States $0.182B 0.00
XOMA (XOMA) United States $0.179B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Liquidia Technologies (LQDA) United States $0.173B 0.00
Cerecor (CERC) United States $0.172B 0.00
Aytu Bioscience (AYTU) United States $0.168B 0.00
VTv Therapeutics (VTVT) United States $0.166B 0.00
Bellus Health (BLU) Canada $0.161B 0.00
Kindred Biosciences (KIN) United States $0.157B 0.00
Cidara Therapeutics (CDTX) United States $0.156B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.142B 0.00
Celyad SA (CYAD) Belgium $0.142B 0.00
Cyclerion Therapeutics (CYCN) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
Gritstone Oncology (GRTS) United States $0.134B 0.00
VolitionRX (VNRX) United States $0.133B 0.00
Palatin Technologies (PTN) United States $0.131B 3.35
Windtree Therapeutics (WINT) United States $0.122B 0.00
PHASEBIO PHARMA (PHAS) United States $0.122B 0.00
Orgenesis (ORGS) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.118B 0.00
Lumos Pharma (LUMO) United States $0.118B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
Oncobiologics (OTLK) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
CorMedix Inc (CRMD) United States $0.114B 0.00
Cardiff Oncology (CRDF) United States $0.114B 0.00
SESEN BIO, INC (SESN) United States $0.110B 0.00
Cocrystal Pharma (COCP) United States $0.108B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.103B 0.00
AIT Therapeutics (XAIR) United States $0.098B 0.00
AquaBounty Technologies (AQB) United States $0.098B 0.00
Organovo Holdings (ONVO) United States $0.092B 0.00
ARAVIVE, INC (ARAV) United States $0.089B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.084B 0.00
Unum Therapeutics (UMRX) United States $0.082B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
DiaMedica Therapeutics (DMAC) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Proteostasis Therapeutics (PTI) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.074B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.073B 0.00
Synlogic (SYBX) United States $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 97.50
ANIXA BIOSCIENCES INC (ANIX) United States $0.067B 0.00
Edesa Biotech (EDSA) Canada $0.067B 0.00
Bionano Genomics (BNGO) United States $0.067B 0.00
Soligenix (SNGX) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
IMMURON (IMRN) Australia $0.062B 0.00
AnPac Bio-Medical Science (ANPC) China $0.061B 0.00
Happiness Biotech Group (HAPP) China $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.058B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Genetic Technologies (GENE) Australia $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.050B 0.00
Spherix (AIKI) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Celsion (CLSN) United States $0.039B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.00
Cesca Therapeutics (THMO) United States $0.036B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Prana Biotechnology (ATHE) Australia $0.035B 0.00
OvaScience (MLND) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.031B 0.00
Novogen (KZIA) Australia $0.031B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
MYOS RENS Technology (MYOS) United States $0.023B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Neuralstem (SNCA) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00